OBESITY - AN ELEMENT OF METABOLIC SYNDROME

The US National Program for Cholesterol Education proposes a more streamlined definition for clinical practice, but does not include insulin resistance. [...]people with MS must meet three of the following criteria: - high blood pressure (> 130 / 85mmHg) - high plasma glucose (> 110 mg / dl) - abdominal obesity (abdominal circumference> 102 cm in males and > 88 cm in women) - low serum HDL-cholesterol (< 40 md/dl in men and < 50 mg/dl in women) - elevated serum triglyceride levels (> 150 mg /dll). The first data retained from the clinical observation sheets were those of a general nature: the age of the patients; sex; the residence environment. [...]patients were divided into age groups (4049 years, 50-59 years, 60-69 years) by gender (male / female) and by country of origin (rural / urban). Starting from the notion that obesity and insulin-resistance imply heavy hepatocyte loading, the study aims to evaluate the prevalence of hepatosteatosis in obese patients. [...]from the data provided by the imaging investigations, we used the ultrasound assessments performed in the liver and the cholecysterase and we noted the cases with hepatic steatosis and gallstones. Using data from liver ultrasound exploration, cases of obese patients were subdivided into the following categories: hepatic steatosis; with mild hepatic steatosis; with moderate hepatic steatosis; with severe hepatic steatosis. [...]we identified in the general study group: 6 cases of patients without steatosis-type liver disease, 20 obese patients with mild hepatic steatosis, 70 patients with moderate steatosis and 14 patients with severe steatosis.